A cross-sectional study to evaluate the usefulness of non-invasive hepatic fibrosis marker including Mac-2 binding protein (M2BP) and asialo a1-acid glycoprotein (AsAGP) and insulin resistance marker as a diagnostic indicator of liver fibrosis in the ultrasound-diagnosed fatty liver patients.
Not Applicable
Completed
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0004462
- Lead Sponsor
- Hanyang University Seoul Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2432
Inclusion Criteria
We will use medical records from March 1, 2019 to May 31, 2019 for those who performed health check-ups including abdominal sonography at Hanyang University Medical Center.
Exclusion Criteria
1) Foreigner
2) Missing data for skeletal muscle, sonography or alcohol consumption
3) Viral hepatitis positive or chronic liver disease
4) Alcohol consumption (>210 g for men and >140 g for women
5) Person who take a medication causing fatty liver such as steoid
6) No remnant blood sample
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean value of target variables such as AsAGP, M2BP, Fib-4, NFS
- Secondary Outcome Measures
Name Time Method Mean analysis of target variables accoding to non alcoholic fatty liver disease